In the third quarter, Smith & Nephew saw revenue grow 1 percent over the same period last year, although trading profit was up 22 percent, according to a release from Smith and Nephew.
In Smith & Nephew’s orthopedics division, improved reconstruction performance was offset by weaker trauma sales in the third quarter.
The company said it sees early signs of the market stabilizing as spending on surgical procedures resumes.
Read the release on Smith & Nephew’s third quarter sales.
Captiva Spine doubled its revenue year-over-year in the first quarter of 2025, largely due to accelerated market adoption of its…
Ten thousand patients have been treated with Augmedics’ Xvision augmented reality spine system, the company said April 22. The milestone…
The highest-paid CFO of orthopedic medtech companies in the U.S. saw more than $12 million per year in total compensation…
Comments are closed.